1. 1750PAssessment of socio-economic, physical and mental health status of long-term cancer survivors. (23rd October 2018) Authors: Gallego Martínez, A; Martínez, B; Ghanem, I; Espinosa, E; Castelo, B; Zamora Aunon, M P; Pinto Marin, A; Ruiz-Giménez, L; Redondo, A; Feliu Batlle, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bevacizumab combined with first-line carboplatin and paclitaxel for metastatic/recurrent/persistent cervical cancer: primary results from the global single-arm phase II CECILIA study. (1st November 2019) Authors: Colombo, N; Dreosti, L; McCormack, M; Nogueira-Rodrigues, A; Scambia, G; Roszak, A; Donica, M; Ulker, B; González-Martín, A; Redondo, A Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study. (1st November 2019) Authors: González-Martín, A; Pothuri, B; Vergote, I; Christensen, RD; Graybill, W; Mirza, MR; McCormick, C; Lorusso, D; Hoskins, P; Freyer, G; Baumann, K; Jardon, K; Redondo, A; Moore, RG; Vulsteke, C; O'Cearbhaill, RE; Lund, B; Backes, F; Barretina-Ginesta, P; Haggerty, AF Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety and dose modification for patients receiving niraparib. (13th August 2018) Authors: Berek, J S; Matulonis, U A; Peen, U; Ghatage, P; Mahner, S; Redondo, A; Lesoin, A; Colombo, N; Vergote, I; Rosengarten, O; Ledermann, J; Pineda, M; Ellard, S; Sehouli, J; Gonzalez-Martin, A; Berton-Rigaud, D; Madry, R; Reinthaller, A; Hazard, S; Guo, W Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Safety and dose modification for patients receiving niraparib. (14th May 2018) Authors: Berek, J S; Matulonis, U A; Peen, U; Ghatage, P; Mahner, S; Redondo, A; Lesoin, A; Colombo, N; Vergote, I; Rosengarten, O; Ledermann, J; Pineda, M; Ellard, S; Sehouli, J; Gonzalez-Martin, A; Berton-Rigaud, D; Madry, R; Reinthaller, A; Hazard, S; Guo, W Journal: Annals of oncology Issue: Volume 29:Number 8(2018) Page Start: 1784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗